序号 |
标题 |
次数 |
作者 |
发布时间 |
75151 |
DNP-PEG1-CH2 acid的分子结构,1522301-61-6 |
108 |
wyh |
2024-12-24 |
75152 |
5,10,15,20-四(4-甲氧基-3-磺酸苯基)卟啉[T(4-MOP)PS4] |
178 |
WYQ |
2024-12-24 |
75153 |
Phe-Lys(Fmoc)-PAB ,抗体- 药物偶联物 |
170 |
hyy |
2024-12-24 |
75154 |
3,3'-二(3,4-二羧基苯氧基)-4,4'-二苯乙炔基联苯二酐(BPEBPDA) |
104 |
WYQ |
2024-12-24 |
75155 |
mPEG9-OCH2CH2COONHS Ester的介绍 |
104 |
zyl |
2024-12-24 |
75156 |
Ald-benzoylamide-PEG3-CH2 acid的主要功能与应用,1007215-91-9 |
102 |
wyh |
2024-12-24 |
75157 |
多孔卟啉基超支化聚酰亚胺(PPBPI-1-CR、PPBPI-2-CR) |
173 |
WYQ |
2024-12-24 |
75158 |
mPEG4-OCH2CH2COONHS Ester cas:874208-94-3 |
110 |
zyl |
2024-12-24 |
75159 |
Boc-Arg(di-Z)-OHVal-Cit-PAB-Eribulin,CAS: 2130869-21-3 |
132 |
h |
2024-12-24 |
75160 |
5,10,15,20-四[4-[(3-氨基苯基)乙炔基]苯基]卟啉(TAPEPP) |
161 |
WYQ |
2024-12-24 |
75161 |
Boc-Arg(di-Z)-OH,Boc-2-Z-L-精氨酸,CAS号:51219-19-3 |
97 |
h |
2024-12-24 |
75162 |
HO-PEG45-DAG的介绍 |
188 |
zyl |
2024-12-24 |
75163 |
Val-Cit-PAB-OH,ADC试剂,159857-79-1 |
166 |
hyy |
2024-12-24 |
75164 |
5,10-二(4-氨基苯基)-15,20-二苯基卟啉(Cis-DADPPH2) |
119 |
WYQ |
2024-12-24 |
75165 |
维甲酸甘草黄酮脂质体,Retinoic Acid-Glycyrrhizic Flavone Liposome |
149 |
axc |
2024-12-24 |
75166 |
BOC保护的丙氨酸锌卟啉(Zn·TAPP-Ala-BOC) |
126 |
WYQ |
2024-12-24 |
75167 |
Pebac; D-Phenylalanyl-prolyl-arginyl Chloromethyl Ketone; D-Phe-Pro-Arg-CH2Cl |
99 |
h |
2024-12-24 |
75168 |
Phthalamidoxy-PEG1-CH2-ald的主要特点与功能 |
103 |
wyh |
2024-12-24 |
75169 |
HO-PEG36-DSG的介绍 |
108 |
zyl |
2024-12-24 |
75170 |
PPACK dihydrochloride,CAS号:142036-63-3,D-苯丙氨酸-脯氨酸-精氨酸-氯甲酮盐酸盐 |
171 |
h |
2024-12-24 |
75171 |
维甲酸脂质体,Retinoic Acid Liposome |
108 |
axc |
2024-12-24 |
75172 |
N-Phthaloyl-β-alanine,3-邻二甲酰亚氨基丙酸,CAS号:3339-73-9 |
127 |
h |
2024-12-24 |
75173 |
Ac-VLPE-FMK,CAS号:2679825-27-3 |
90 |
h |
2024-12-24 |
75174 |
DSG-PEG44-CH2CH2NH2的化学性质 |
112 |
zyl |
2024-12-24 |
75175 |
(S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH |
99 |
h |
2024-12-24 |
75176 |
伊立替康脂质体,Irinotecan Liposome |
267 |
axc |
2024-12-24 |
75177 |
Mal-NH-PEG7-COOH; Maleimide-NH-PEG7-CH2CH2COOH |
200 |
h |
2024-12-24 |
75178 |
Mal-amido-PEG7-acid,CAS号:2112731-42-5 |
93 |
h |
2024-12-24 |
75179 |
前列地尔脂质体,Alprostadil Liposome |
148 |
axc |
2024-12-24 |
75180 |
DSG-PEG45-OMe的介绍 |
118 |
zyl |
2024-12-24 |
75181 |
H2N-PEG27-CH2CH2NH2 |
99 |
h |
2024-12-24 |
75182 |
5,10-(2,2'-(1,2-乙二氧基)二-5-叔丁基苯基)-15,20-(2,2'-(1,2-乙二氧基)二-5-叔丁基苯基)卟啉1-Zn |
145 |
WYQ |
2024-12-24 |
75183 |
Amino-PEG27-amine,CAS号:2252208-09-4 |
114 |
h |
2024-12-24 |
75184 |
米托蒽醌脂质体,Mitoxantrone Liposome |
236 |
axc |
2024-12-24 |
75185 |
DMG-PEG24 二肉豆蔻酰-二十四聚乙二醇 |
96 |
zyl |
2024-12-24 |
75186 |
H2N-PEG15-CH2CH2NH2 |
78 |
h |
2024-12-24 |
75187 |
DSPE-PEG36-NH2 磷脂-三十六聚乙二醇-氨基 |
103 |
zyl |
2024-12-24 |
75188 |
Amino-PEG15-amine |
85 |
h |
2024-12-24 |
75189 |
5,10,15,20-四(五氟苯基)卟啉(TF5PPH2) |
139 |
WYQ |
2024-12-24 |
75190 |
Amino-PEG12-amine,CAS号:361543-12-6 |
76 |
h |
2024-12-24 |
75191 |
mPEG6-OCH2CH2COO-Naltrexone的结构式 |
127 |
zyl |
2024-12-24 |
75192 |
Mal-PEG2-CH2COOH的结构特点,173323-23-4 |
162 |
wyh |
2024-12-24 |
75193 |
H2N-PEG13-CH2CH2NH2,CAS号:1228119-65-0 |
110 |
h |
2024-12-24 |
75194 |
7-5-(4-硝基苯基)-10, 15, 20-三苯基镁卟啉(MgTPPNO2) |
109 |
WYQ |
2024-12-24 |
75195 |
Amino-PEG13-amine,CAS号:1228119-65-0 |
102 |
h |
2024-12-24 |